Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Catella A | CATA | 13. nov 2024 | 28.60 | +0.70 |
Catella B | CATB | 13. nov 2024 | 28.85 | +0.52 |
Catena | CATE | 13. nov 2024 | 495.50 | -0.50 |
Catena Media | CTM | 13. nov 2024 | 4.20 | -3.34 |
Cavendish Hydrogen | CAVENO | 13. nov 2024 | 11.00 | 0.00 |
Cavotec SA | CCC | 13. nov 2024 | 16.75 | -1.76 |
CDON | CDON | 13. nov 2024 | 95.00 | 0.00 |
Cedergrenska | CEDER | 13. nov 2024 | 27.00 | 0.00 |
Cell Impact | CI | 13. nov 2024 | 0.17 | -4.16 |
CellaVision | CEVI | 13. nov 2024 | 239.00 | -1.44 |
Cereno Scientific B | CRNOB | 13. nov 2024 | 4.91 | -0.61 |
ChargePanel AB (publ) | CHARGE | 13. nov 2024 | 1.48 | -2.63 |
Checkin.com Group | CHECK | 13. nov 2024 | 17.50 | +9.03 |
Cheffelo | CHEF | 13. nov 2024 | 25.70 | -1.15 |
Chordate Medical Holding | CMH | 13. nov 2024 | 22.30 | -0.45 |
Chosa Oncology AB | CHOSA | 13. nov 2024 | 0.57 | -6.23 |
ChromoGenics | CHRO | 13. nov 2024 | 9.78 | 0.00 |
Cibus Nordic Real Estate | CIBUS | 13. nov 2024 | 170.25 | -0.55 |
Cinclus Pharma Holding AB | CINPHA | 13. nov 2024 | 22.40 | +3.20 |
Cinis Fertilizer AB | CINIS | 13. nov 2024 | 16.58 | 0.00 |
Cint Group | CINT | 13. nov 2024 | 13.00 | +3.59 |
CirChem | CIRCHE | 13. nov 2024 | 2.60 | -1.52 |
Circle Energy Sweden B | CIRCLEB | 13. nov 2024 | 0.00 | +5.26 |
Clas Ohlson B | CLASB | 13. nov 2024 | 190.00 | -1.20 |
Clavister Holding | CLAV | 13. nov 2024 | 1.76 | -4.35 |
Clean Motion | CLEMO | 13. nov 2024 | 0.41 | +7.37 |
Clemondo Group | CLEM | 13. nov 2024 | 0.83 | +0.97 |
Climeon B | CLIMEB | 13. nov 2024 | 0.35 | -8.51 |
Clinical Laserthermia Systems B | CLSB | 13. nov 2024 | 4.08 | +0.49 |
Cloetta | CLAB | 13. nov 2024 | 25.86 | -0.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.